{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-027037","form_type":"8-K","ticker":"IDXG","cik":"0001054102","company_name":"INTERPACE BIOSCIENCES, INC.","filed_at":"2021-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.293263+00:00","generated_at":"2026-06-28T13:39:32.692262+00:00","sec_items":["1.01","2.03","8.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Interpace enters $8M term loan with BroadOak at 9% to repay private equity loans","bullets":["$8M term loan from BroadOak at 9% interest, matures Oct 2024 or change-of-control.","Proceeds used to repay $4.5M Ampersand and $3M 1315 Capital promissory notes plus interest.","Loan includes 3% origination fee and terminal payment of 15%-30% of original principal.","Subordinate to Comerica's $7.5M revolving facility; secured by substantially all assets.","Company believes new debt improves liquidity and operating flexibility without dilution."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-027037","json":"https://secwatch.observer/filing/0001493152-21-027037.json","markdown":"https://secwatch.observer/filing/0001493152-21-027037.md","text":"https://secwatch.observer/filing/0001493152-21-027037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1054102/000149315221027037/0001493152-21-027037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1054102/000149315221027037/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T13:39:32.692262+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}